Chlorogenic acid fails to confer neuroprotection in a chronic mouse model of Parkinson’s disease
Authors:
Preprint
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by α-Synuclein (α-Syn) aggregation, dopaminergic neuronal loss, and chronic neuroinflammation. Chlorogenic acid (CA), a dietary polyphenol abundant in coffee, exhibits antioxidant and anti-inflammatory properties and has shown neuroprotective effects in acute toxin-based PD models. However, its efficacy in chronic, α-Syn–driven PD models remains unclear. Here, we evaluated the therapeutic potential of CA using an α-Syn–based in vitro system and a chronic α-Syn overexpression mouse model that recapitulates key pathological features of human PD. In vitro , CA significantly improved cell viability, reduced α-Syn aggregation, and attenuated H 2 O 2 -induced apoptosis in U118 and N2a cells. In contrast, chronic oral administration of CA (100 mg/kg for 16 weeks) in C57BL/6J mice (male and female) failed to improve motor behavior, attenuate α-Syn pathology, preserve nigrostriatal dopaminergic neurons, or reduce oxidative stress–associated DNA double-strand breaks in vivo . Notably, CA elicited a modest reduction in microglial and astrocytic activation in female mice, highlighting a sex-dependent immunomodulatory response. Collectively, these findings reveal a clear dissociation between robust in vitro neuroprotection and limited in vivo efficacy in a chronic α-Syn–driven PD mouse model, emphasizing the importance of incorporating progressive disease paradigms and sex as a biological variable in preclinical therapeutic evaluation.Keywords
Funding Information
- Cure Parkinson's Trust (PT01)
- Wellcome Trust DBT India Alliance (IA/E/17/1/503664)
- Anusandhan National Research Foundation (SRG/2021/000981)
This publication has 51 references indexed in Scilit:
- Oxidative Stress: Signaling Pathways, Biological Functions, and DiseaseMedcomm, 2025
- Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in MiceNeurochemical Research, 2025
- Neuroprotective effect of chlorogenic acid on Parkinson's disease like symptoms through boosting the autophagy in zebrafishEuropean Journal of Pharmacology, 2023
- Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 SecretionMolecular Neurobiology, 2022
- Parkinson's disease in women: Mechanisms underlying sex differencesEuropean Journal of Pharmacology, 2021
- α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body diseaseActa Neuropathologica, 2019
- Chlorogenic acid (CGA): A pharmacological review and call for further researchBiomedicine & Pharmacotherapy, 2018
- Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon MetabolismBrain Research Bulletin, 2017
- Eucommia ulmoides Oliv. Bark. protects against hydrogen peroxide-induced neuronal cell death in SH-SY5Y cellsJournal of Ethnopharmacology, 2012
- Prospective study of caffeine consumption and risk of Parkinson's disease in men and womenAnnals of Neurology, 2001